Skip to main content
Clinical Trials/CTRI/2021/01/030500
CTRI/2021/01/030500Not yet recruitingPhase 3

Comparative study between Tramadol and Butorphanol as an adjuvant to Bupivacaine for supraclavicular brachial plexus block.

Self0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Self

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • ASA-PS I and II patients posted for upper limb orthopedic surgeries under Supraclavicular brachial plexus block.

Exclusion Criteria

  • Patient refusal,
  • Morbidly obese patients (body mass index >35 kg/m2),
  • Pregnant or lactating women,
  • Allergy or addiction to study drugs,
  • Patients receiving chronic analgesic therapy,
  • Coagulopathies, and
  • Pre-existing peripheral neuropathy

Investigators

Sponsor
Self

Similar Trials

To compare two drugs when used with a... | Clinical Trial